TrialJournal of diabetes research2018

Intralymphatic Glutamic Acid Decarboxylase-Alum Administration Induced Th2-Like-Specific Immunomodulation in Responder Patients: A Pilot Clinical Trial in Type 1 Diabetes.

Beatriz Tavira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.